XBiotech

XBiotech is a biopharmaceutical company that develops antibody therapies for inflammatory diseases and colorectal cancer. Read more

John Simard's photo - Chairman & CEO of XBiotech

Chairman & CEO

John Simard

CEO Approval Rating

80/100

Founded:

2005

Status:

PublicIndependent CompanyNASDAQXBIT

XBIOTECH TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

XOMA is perceived as one of XBiotech's biggest rivals. XOMA was founded in 1981 in Emeryville, California. XOMA is in the Pharmaceuticals field. XOMA generates $7.2M less revenue than XBiotech.

Aclaris is XBiotech's #2 rival. Aclaris is a Public company that was founded in 2012 in Wayne, Pennsylvania. Aclaris competes in the Pharmaceuticals field. Compared to XBiotech, Aclaris has 1 more employees.

Elcelyx Therapeutics is one of XBiotech's top competitors. Elcelyx Therapeutics's headquarters is in San Diego, California, and was founded in 2009. Elcelyx Therapeutics operates in the Health Care Services industry. Elcelyx Therapeutics generates 12% of XBiotech's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is InflaRx a competitor of XBiotech?

XBiotech Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$36.2M

XBiotech's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 3.5B. Over the last three quarters, XBiotech's revenue has decreased by 84.4%. Specifically, in Q1 2021's revenue was $4.8M; in Q3 2020, it was $10.5M; in Q2 2020, it was $31M.

XBiotech Acquisitions

No recent acquisitions found related to XBiotech

XBiotech Funding History

Since XBiotech was founded in 2005, it has participated in 1 round of funding. In total XBiotech has raised $76.0M. XBiotech's funding round was on Apr 2015 for a total of $76.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Apr 2015
$76M
-

Since XBiotech was founded in 2005, it has participated in 1 round of funding. In total XBiotech has raised $76.0M. XBiotech's funding round was on Apr 2015 for a total of $76.0M

XBiotech Investments

No recent investments found related to XBiotech

XBiotech News

January 21, 2021FE Investegate

XBiotech Candidate True Human COVID-19 Therapy Found to Target Highly Infectious Emerging Strain

1:15 PM: XBiotech Candidate True Human COVID-19 Therapy Found to Target Highly Infectious Emerging S... See more »
December 23, 2020The Business Journals

XBiotech to expand Austin HQ with more offices, state-of-the-art R&D facility

Biopharmaceutical company XBiotech is planning some major upgrades to coincide with the launch of new... See more »
November 20, 2020Manufacturing Chemist

XBiotech Fluvid therapy to treat influenza and COVID-19 infections

The latest research findings suggest the therapy, designed to be effective against all known strains ... See more »
November 19, 2020FE Investegate

XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail

1:15 PM: XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate... See more »

XBiotech Press Releases

XBiotech Videos

September 14, 2020XBiotech Youtube Channel

"360 Virtual Cleanroom Tour" on YOUTUBE

July 29, 2020XBiotech Youtube Channel

"XBiotech Headquarters" on YOUTUBE

June 23, 2020XBiotech Youtube Channel

"XBiotech - "We Believe"" on YOUTUBE

Social Media

XBiotech Headquarters

5217 Winnebago Lane

Austin, Texas78744

512-386-2900

Driving Directions »

Trending Companies

XBiotech Summary

ABOUT

Overview

XBiotech is a biopharmaceutical company that develops antibody therapies for inflammatory diseases and colorectal cancer. XBiotech was founded in 2005. XBiotech's headquarters is located in Austin, Texas, USA 78744. It has raised 76.0M in 1 round. The...

CEO

XBiotech's Chairman & CEO, John Simard, currently has an approval rating of 80%. XBiotech's primary competitors are XOMA, Aclaris & Elcelyx Therapeutics.

Frequently Asked Questions about XBiotech

  1. When was XBiotech founded?

    XBiotech was founded in 2005
  2. Who is XBiotech's CEO?

    XBiotech's CEO is John Simard
  3. How much revenue does XBiotech generate?

    XBiotech generates $36.2M in revenue
  4. How much funding does XBiotech have?

    XBiotech has historically raised $76M in funding
  1. Where is XBiotech's headquarters?

    XBiotech's headquarters is in Austin Texas, USA
  2. How many employees does XBiotech have?

    XBiotech has 56 employees
  3. What sector does XBiotech operate in?

    XBiotech is in Biotechnology
  4. Who are XBiotech's competitors?

    XBiotech's top competitors are XOMA, Aclaris, Elcelyx Therapeutics